Radiation-induced Xerostomia
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
MeiraGTxNEW YORK, NY
1 programLong-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced XerostomiaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Martin PharmaceuticalsHyperbaric oxygen
MeiraGTxLong-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
Clinical Trials (2)
Total enrollment: 35 patients across 2 trials
Hyperbaric Oxygen for the Treatment of a Dry Mouth Which Occurred After Radiotherapy
Start: May 2008Est. completion: Mar 201113 patients
Phase 2Terminated
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
Start: Nov 2020Est. completion: Mar 202722 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.